Radiation dosimetry for therapy of neuroblastoma
- 1 October 1996
- journal article
- research article
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 41 (10) , 1933-1940
- https://doi.org/10.1088/0031-9155/41/10/006
Abstract
This paper describes the methodology which can be used to determine whole-body, red marrow, blood, bladder, liver, and tumour doses delivered during therapy of neuroblastoma. The methodology is based on the Physics Protocol used in a multi-centre study undertaken by the United Kingdom Children's Cancer Study Group (UKCCSG). In this study, the estimates of the doses delivered, using 2.4 - 12.1 GBq , were in the following ranges: whole body, ; red marrow, ; blood, ; bladder, ; liver, ; and tumour, .Keywords
This publication has 4 references indexed in Scilit:
- Dosimetric considerations in 131I-MIBG therapy for neuroblastoma in childrenThe British Journal of Radiology, 1995
- Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Children's Cancer Study Group investigation.Journal of Clinical Oncology, 1992
- The treatment of resistant neuroblastoma with 131I-mIBG: alternative methods of dose prescriptionRadiotherapy and Oncology, 1992
- The biodistribution and pharmacokinetics of meta-iodobenzylguanidine in childhood neuroblastomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 1988